Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Fetterman, Jessica L ^a   Holbrook, Monica ^a   Westbrook, David G ^b   Brown, Jamelle A ^b   Feeley, Kyle P ^b   Bretón Romero, Rosa ^a   Linder, Erika A ^a   Berk, Brittany D ^a   Weisbrod, Robert M ^a   Widlansky, Michael E ^c   Gokce, Noyan ^a   Ballinger, Scott W ^b   Hamburg, Naomi M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLOW MEDIATED DILATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL DNA DISORDER; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PULSE WAVE; QUANTITATIVE ANALYSIS; VASODILATATION; AGED; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; COMPLICATION; GENETICS; HYPEREMIA; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

MITOCHONDRIAL DNA;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; DIABETES MELLITUS, TYPE 2; DNA, MITOCHONDRIAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS;

EID: 84977505897     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0372-y     Document Type: Article

References (28)

1. Mozaffarian D, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322.
2. Danaei G, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31-40.
3. Harrison D, et al. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91(3A):7A-11A.
4. Schulz E, Anter E, Keaney JF Jr. Oxidative stress, antioxidants, and endothelial function. Curr Med Chem. 2004;11(9):1093-104.
5. Chinnery PF, et al. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol. 2000;47(3):381-4.
6. Widlansky ME, Gutterman DD. Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid Redox Signal. 2011;15(6):1517-30.
7. Widlansky ME, et al. Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Transl Res. 2010;156(1):15-25.
8. Kizhakekuttu TJ, et al. Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2012;32(10):2531-9.
9. Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94(2):514-9.
10. Ballinger SW, et al. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp Eye Res. 1999;68(6):765-72.
11. Mercer JR, et al. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res. 2010;107(8):1021-31.
12. Yu EP, Bennett MR. Mitochondrial DNA damage and atherosclerosis. Trends Endocrinol Metab. 2014;25(9):481-7.
13. Hartman ML, et al. Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus. Vasc Med. 2014;19(1):67-74.
14. McMackin CJ, Vita JA. Update on nitric oxide-dependent vasodilation in human subjects. Methods Enzymol. 2005;396:541-53.
15. Hamburg NM, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117(19):2467-74.
16. Hamburg NM, et al. Relation of brachial and digital measures of vascular function in the community: the Framingham heart Study. Hypertension. 2011;57(3):390-6.
17. Ballinger SW, et al. Mitochondrial genome damage associated with cigarette smoking. Cancer Res. 1996;56(24):5692-7.
18. Yu E, et al. Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation. 2013;128(7):702-12.
19. Ballinger SW, et al. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res. 2000;86(9):960-6.
20. Pinto M, Moraes CT. Mechanisms linking mtDNA damage and aging. Free Radic Biol Med. 2015;85:250-8.
21. Kaguni LS. DNA polymerase gamma, the mitochondrial replicase. Annu Rev Biochem. 2004;73:293-320.
22. Botto N, et al. Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res. 2005;570(1):81-8.
23. Nomiyama T, et al. Accumulation of somatic mutation in mitochondrial DNA and atherosclerosis in diabetic patients. Ann NY Acad Sci. 2004;1011:193-204.
24. Kluge MA, Fetterman JL, Vita JA. Mitochondria and endothelial function. Circ Res. 2013;112(8):1171-88.
25. Shenouda SM, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011;124(4):444-53.
26. Schnabel RB, et al. Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging. 2011;4(4):371-80.
27. Matsuzawa Y, et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc. 2013;2(6):e000426.
28. Paneni F, et al. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes. Eur Heart J. 2015;36(13):817-28.